Gilead Sciences
NASDAQ: GILD
$65.05
+$0.01 (+0.0%)
Closing price September 18, 2020
Gilead Sciences would not be the first company to pile on more debt to make an acquisition, but it is now eating deep into its cash for this acquisition.
1 day ago
Last Updated: 1 day ago
These four high-conviction health care stock ideas from the analysts at Jefferies all make sense for investors looking to gain exposure to a sector that should continue to do well the rest of 2020...
5 days ago
Immunomedics shares more than doubled on Monday after the firm announced that it would be acquired by Gilead Sciences in one of the biggest deals to go down in the health care sector this year.
6 days ago
Monday's top analyst upgrades and downgrades included Adobe, BP, FedEx, GameStop, Gilead Sciences, Kroger, MGM Resorts, Micron Technology, Nvidia and Tradeweb Markets.
6 days ago
Last Updated: 6 days ago
The August 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
9 days ago
Last Updated: 9 days ago
Practically any biotech company attempting almost anything COVID-19 related has seen massive gains. However, there is likely more to come for the rest of the year and into next year. These five...
10 days ago
Jounce Therapeutics Inc. (NASDAQ: JNCE) made a massive gain on Tuesday after the company announced a licensing agreement with Gilead Sciences Inc. (NASDAQ: GILD). This deal is for the discovery and...
19 days ago
The August 14 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
25 days ago
The FDA has come down on an investigational treatment for moderately to severely active from Gilead Sciences and Galapagos.
1 month ago
Wednesday's top analyst upgrades and downgrades included Agilent Technologies, Cree, Deere, Gilead Sciences, Home Depot, Kohl's, Nordstrom, Walmart and Walt Disney.
1 month ago
Last Updated: 1 month ago
The July 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
1 month ago
24/7 has compiled a few biopharmaceutical names that have lagged the markets and recently have reported earnings. In a sense, the fundamentals have shown some light on these stocks, that they may be...
1 month ago
Last Updated: 1 month ago
The July 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
1 month ago
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
1 month ago
Stocks were looking for direction on Monday ahead of this week’s earnings deluge. With an election coming up and with what is still a very deep recession, investors need to be considering how...
2 months ago
Last Updated: 1 month ago